GN
George K Ng
Chief Executive Officer

George K Ng insider trades: Processa Pharmaceuticals (PCSA) stock buys and sales

Chief Executive Officer, Processa Pharmaceuticals Last trade Jul 1, 2026 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$44K
Bought, last 12 months
8 buys
14
Open-market trades
since 2015
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where George reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 1, 2026PCSA↑ Buy$6K
Jun 15, 2026PCSA↑ Buy$5K
May 15, 2026PCSA↑ Buy$5K
Apr 15, 2026PCSA↑ Buy$5K
Apr 15, 2026PCSA↑ Buy$5K
Apr 15, 2026PCSA↑ Buy$5K
Mar 31, 2026PCSA↑ Buy$5K
Mar 31, 2026PCSA↑ Buy$5K
Jan 27, 2025PCSA↑ Buy$70K
Jan 30, 2024PCSA↑ Buy$27K
Feb 28, 2018SRNE↑ Buy$895K
Feb 3, 2017SRNE↓ Sell$206K
Aug 21, 2015SRNE↑ Buy$12K
Aug 3, 2015SRNE↑ Buy$132K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PCSA insiders

Open-market trades in the last 12 months

About George K Ng's insider trades

George K Ng is Chief Executive Officer at Processa Pharmaceuticals (PCSA). Since Aug 3, 2015, George has reported 13 open-market purchases worth $1.2M and 1 sale worth $206K on SEC Form 4. In the last 12 months: 8 buys ($44K).

Their filings also include grants and awards (13 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.